LEGAL STATUS OF CONTINUOUS PHYSIOLOGICAL PREDICTION SYSTEMS

1. INTRODUCTION

Continuous physiological prediction systems are technologies that collect physiological measurements over time and use statistical models, artificial intelligence, or machine learning to predict an individual's health condition or future medical events. Examples include wearable devices predicting cardiac abnormalities, glucose-monitoring systems forecasting hypoglycaemia, algorithms estimating respiratory deterioration, and platforms predicting physiological instability in hospital patients.

Their legal status depends primarily on their intended medical purpose, the nature of the predictions, the consequences of an incorrect result, and the personal data they process. A system marketed solely for general fitness may be treated differently from software intended to predict disease, trigger clinical alerts, or guide treatment.

In India, the principal regulatory framework includes the Drugs and Cosmetics Act, 1940, the Medical Devices Rules, 2017, constitutional privacy protections, applicable data-protection legislation, and consumer-protection law. There is no single statute exclusively governing every continuous physiological prediction system.

2. REGULATORY FRAMEWORK IN INDIA

A. MEDICAL DEVICE CLASSIFICATION

Under section 3(b)(iv) of the Drugs and Cosmetics Act, 1940, the definition of a medical device includes qualifying software intended for purposes such as diagnosing, preventing, monitoring, treating, or alleviating disease, or investigating or supporting a physiological process.

The Medical Devices Rules, 2017 establish a risk-based framework for medical devices. Depending on the applicable classification and intended use, manufacturers and other regulated parties may need to satisfy licensing, safety, performance, quality-management, labelling, and post-market obligations.

A general-wellness wearable does not automatically become a medical device merely because it measures heart rate, sleep, or activity. However, software intended to predict a disease, provide clinically actionable alerts, or support medical decisions may fall within the regulated medical-device framework. Regulatory classification must be determined from the product's actual intended purpose and functionality, not simply its commercial label. The CDSCO's 2026 guidance on medical-device software provides further clarification on software classification and technical documentation. <Cite refs={["turn772029search0","turn772029search21","turn772029search8"]}/>

B. PRIVACY AND PERSONAL DATA

Continuous monitoring generates detailed information about bodily functions, daily activities, and possible health conditions. Such information can be highly revealing even when a device does not explicitly record a diagnosis.

The Supreme Court's recognition of privacy as a fundamental right in Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) is central to evaluating the collection, use, and disclosure of physiological data. Organisations must assess applicable privacy legislation, lawful processing grounds, notice and consent requirements where relevant, security safeguards, retention, and third-party sharing.

The Digital Personal Data Protection Act, 2023 and its implementing rules must be applied according to their notified commencement and transitional provisions. Where the Information Technology Act, 2000 and the Information Technology (Reasonable Security Practices and Procedures and Sensitive Personal Data or Information) Rules, 2011 remain applicable, their requirements must also be considered.

3. CORE LEGAL STANDARDS

A. SCIENTIFIC VALIDITY AND CLINICAL VALIDATION: Predictions should be supported by evidence appropriate to the claimed purpose and intended population. Manufacturers should evaluate sensitivity, specificity, calibration, false-positive rates, false-negative rates, and performance across relevant demographic groups.

B. TRANSPARENCY AND EXPLAINABILITY: Users and healthcare professionals should receive understandable information about the system's purpose, limitations, uncertainty, and appropriate response to alerts. Predictions must not be represented as certain diagnoses when the evidence supports only an estimate.

C. HUMAN OVERSIGHT: High-consequence predictions should have appropriate clinical oversight and escalation procedures. The system should clearly identify when professional assessment is necessary and should not silently substitute an unvalidated prediction for a clinical decision.

D. CYBERSECURITY AND DATA INTEGRITY: Encryption, access controls, audit logs, secure updates, incident response, and protection against data manipulation are important safeguards. Altered or delayed physiological measurements can produce dangerous predictions.

E. CONTINUOUS PERFORMANCE MONITORING: Developers and healthcare providers should monitor model drift, device calibration, changing patient populations, software updates, adverse events, and deterioration in predictive accuracy. Significant changes may require renewed validation or regulatory assessment.

F. INFORMED DISCLOSURE AND ACCOUNTABILITY: Terms of use and clinical documentation should describe intended use, known risks, data practices, limitations, and reporting channels. Organisations should preserve evidence of validation, software versions, complaints, and corrective actions.4. RELEVANT CASE LAWS

1. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) — Direct authority on privacy principles. The nine-judge Constitution Bench recognised privacy as a fundamental right under Article 21 and other provisions of Part III of the Constitution. The judgment's recognition of informational privacy is relevant to continuous physiological monitoring, particularly where systems collect intimate health information or infer medical conditions. Its proportionality principles are especially relevant to state-directed monitoring.

Indian Kanoon+1

2. Suchita Srivastava v. Chandigarh Administration (2009) — Analogous authority on bodily autonomy. The Supreme Court recognised reproductive choice as part of personal liberty and bodily integrity under Article 21. Its reasoning supports respect for individual autonomy when physiological monitoring is used in healthcare, although the case did not directly concern predictive technology.

3. Samira Kohli v. Dr. Prabha Manchanda (2008) — Direct analogous authority on informed consent. The Supreme Court explained that valid medical consent must be voluntary and based on adequate information about the nature, purpose, benefits, and material risks of a procedure. The principles are relevant when continuous prediction systems are integrated into clinical care, particularly where monitoring or data use goes beyond what a patient reasonably agreed to.

Indian Kanoon+1

4. Jacob Mathew v. State of Punjab (2005) — Analogous authority on medical negligence. The Supreme Court examined the standard for establishing criminal medical negligence. The case is relevant where healthcare professionals rely on an inaccurate prediction or fail to respond appropriately to an alert. However, an inaccurate algorithm does not automatically establish criminal negligence; the applicable legal elements and professional standard must be proved.

5. Indian Medical Association v. V.P. Shantha (1995) — Analogous authority on consumer protection. The Supreme Court considered the application of consumer protection law to medical services, subject to recognised exceptions. Depending on the facts, defective monitoring services, misleading claims, or inadequate healthcare services involving predictive systems may raise consumer-law issues.

6. Spring Meadows Hospital v. Harjol Ahluwalia (1998) — Analogous authority on healthcare accountability. The Supreme Court addressed liability for medical negligence and the rights of consumers receiving healthcare services. Its reasoning may be relevant when evaluating responsibility for harm involving a monitoring system, although liability depends on the conduct of the parties, causation, and the applicable legal standard.

These judgments establish general principles of privacy, autonomy, consent, negligence, and consumer protection. They do not specifically determine the legal status of continuous physiological prediction systems.

5. PRACTICAL COMPLIANCE REQUIREMENTS

Manufacturers, healthcare institutions, and technology providers should:

Document the system's intended purpose and determine whether it qualifies as a medical device under applicable rules.

Obtain the required authorisations before manufacturing, importing, or marketing a regulated device.

Validate predictive accuracy and document limitations, false alarms, missed events, and population-specific performance.

Explain data collection, prediction purposes, sharing arrangements, and material limitations to users.

Implement appropriate security controls, access restrictions, incident response, and data-retention policies.

Establish clinical escalation procedures and clear allocation of responsibility for responding to alerts.

Monitor post-deployment performance and investigate adverse events, complaints, and unexpected outcomes.

Review product claims, contractual disclaimers, and consumer-facing representations to ensure they do not mislead users or improperly exclude statutory liability.

The CDSCO's Medical Devices Rules, 2017 and its 2026 guidance on medical-device software are important reference points for determining the applicable classification, technical documentation, and safety requirements.

CDSCO+1

6. CONCLUSION

Continuous physiological prediction systems occupy a developing area of medical-device regulation, privacy law, clinical accountability, and artificial intelligence governance. Their legal status depends on intended use, clinical significance, risk classification, data-processing practices, and the consequences of erroneous predictions.

In India, systems intended for medical prediction or monitoring may be subject to the Medical Devices Rules, 2017, while privacy, consumer protection, and professional-liability principles may apply independently. The most defensible approach combines appropriate regulatory authorisation, scientific validation, informed disclosure, secure data processing, human oversight, and continuous performance monitoring.

Legal qualification: The cited cases provide established principles applicable by analogy; they should not be represented as judgments directly regulating predictive physiological algorithms. The precise obligations should be assessed against the current legislation, applicable CDSCO guidance, and the system's specific intended purpose.